Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$3.58 - $10.13 $63,684 - $180,202
-17,789 Reduced 31.68%
38,360 $137,000
Q1 2024

Apr 05, 2024

BUY
$9.22 - $15.02 $362,622 - $590,736
39,330 Added 233.84%
56,149 $588,000
Q3 2023

Nov 06, 2023

BUY
$10.45 - $15.02 $175,758 - $252,621
16,819 New
16,819 $177,000
Q1 2023

May 04, 2023

SELL
$7.32 - $14.38 $155,330 - $305,143
-21,220 Reduced 21.13%
79,190 $1.14 Million
Q4 2022

Feb 06, 2023

BUY
$7.19 - $13.16 $549,028 - $1 Million
76,360 Added 317.51%
100,410 $782,000
Q3 2022

Nov 02, 2022

BUY
$0.0 - $12.8 $0 - $307,840
24,050 New
24,050 $275,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $259M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.